
A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

Last month saw the formation of the Brexit Health Alliance, a partnering of key pharma and life sciences organisations including …

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that …

Still reeling from the public reaction to the flop of its key Mystic trial, where its injectable immunotherapy drug Imfinzi …

The FDA has reputation worldwide as being a standard bearer when it comes to regulating the safety of products and …

Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …

It’s Friday, and it’s been a week characterised by a range of promising research results, particularly into HIV and Duchenne …

The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …